Sikkerheden af fesoterodin blev vurderet i placebokontrollerede kliniske forsøg med i alt 2. 859 patienter med overaktiv blære, hvoraf 780 fik placebo.
The safety of fesoterodine was evaluated in placebo-controlled clinical studies in a total of 2859 patients with overactive bladder, of which 780 received placebo.